Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Silo Pharma, Inc.Financial_Report.xls
EX-31.1 - RULE 13A-14(A) / 15D-14(A) CERTIFICATION OF CHIEF EXECUTIVE OFFICER - Silo Pharma, Inc.f10k2011ex31i_goldswap.htm
EX-31.2 - RULE 13A-14(A) / 15D-14(A) CERTIFICATION OF CHIEF FINANCIAL OFFICER - Silo Pharma, Inc.f10k2011ex31ii_goldswap.htm
EX-32.2 - SECTION 1350 CERTIFICATION OF CHIEF FINANCIAL OFFICER - Silo Pharma, Inc.f10k2011ex32ii_goldswap.htm
10-K - ANNUAL REPORT - Silo Pharma, Inc.f10k2011_goldswap.htm
Exhibit 32.1
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Gold Swap Inc. (the "Company") on Form 10-K for the fiscal year ended December 31, 2011, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Melvin Schlosberg, Chairman, Chief Executive Officer, President and Secretary of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
 
Dated: January 26, 2012

/s/ Melvin Schlossberg
Chairman, Chief Executive Officer, President and Secretary